Skip to main content
http://pbs.twimg.com/media/EJNQrgjWsAIeM4j.jpg
Interesting withdrawal study of tofacitinib in children with JIA showed that drug was better than placebo at preventing disease flares. #pedirheum #ACR19 @RheumNow https://t.co/lHWNJGmmtF
Jonathan Hausmann MD
12-11-2019
×